FDA — authorised 17 September 1976
- Marketing authorisation holder: MOLNLYCKE HLTH
- Status: approved
🇺🇸 Exidine in United States
FDA authorised Exidine on 17 September 1976
Marketing authorisations
FDA — authorised 24 December 1984
- Application: NDA019127
- Marketing authorisation holder: XTTRIUM
- Local brand name: EXIDINE
- Indication: AEROSOL, METERED — TOPICAL
- Status: approved
FDA — authorised 17 December 1985
- Application: NDA019421
- Marketing authorisation holder: XTTRIUM
- Local brand name: EXIDINE
- Indication: SOLUTION — TOPICAL
- Status: approved
Exidine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Exidine approved in United States?
Yes. FDA authorised it on 17 September 1976; FDA authorised it on 24 December 1984; FDA authorised it on 17 December 1985.
Who is the marketing authorisation holder for Exidine in United States?
MOLNLYCKE HLTH holds the US marketing authorisation.